Rapport Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Dr. James I. Healy (“Healy”)(5.5%),Sofinnova Venture Partners XI, L.P. (“SVP XI”)(5.3%), etc.
Rapport Therapeutics | SC 13D: Statement of acquisition of beneficial ownership by individuals-Dr. James I. Healy (“Healy”)(5.5%),Sofinnova Venture Partners XI, L.P. (“SVP XI”)(5.3%), etc.
Rapport Therapeutics | SC 13D：超过5%持股股东披露文件-Dr. James I. Healy (“Healy”)(5.5%),Sofinnova Venture Partners XI, L.P. (“SVP XI”)(5.3%)等